Page 74 - Read Online

Torres et al. J Cancer Metastasis Treat 2018;4:4 I http://dx.doi.org/10.20517/2394-4722.2017.49 Page 21 of 25

135. Lin IY, Van TT, Smooker PM. Live-attenuated bacterial vectors: tools for vaccine and therapeutic agent delivery. Vaccines (Basel)
2015;3:940-72.
136. Inoue H, Tani K. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ
2013;21:39-49.
137. Tsuchiya K, Hara H, Fang R, Hernandez-Cuellar E, Sakai S, Daim S, Chen X, Dewamitta SR, Qu H, Mitsuyama M, Kawamura I. The
adaptor ASC exacerbates lethal Listeria monocytogenes infection by mediating IL-18 production in an inflammasome-dependent and
-independent manner. Eur J Immunol 2014;44:3696-707.
138. Srivastava S, Pelloso D, Feng H, Voiles L, Lewis D, Haskova Z, Whitacre M, Trulli S, Chen YJ, Toso J, Jonak ZL, Chang HC,
Robertson MJ. Effects of interleukin-18 on natural killer cells: costimulation of activation through Fc receptors for immunoglobulin.
Cancer Immunol Immunother 2013;62:1073-82.
139. Cao H, Xiang T, Zhang C, Yang H, Jiang L, Liu S, Huang X. MDA7 combined with targeted attenuated Salmonella vector SL7207/
pBud-VP3 inhibited growth of gastric cancer cells. Biomed Pharmacother 2016;83:809-15.
140. Farooqi A, De Rosa G. TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology.
Appl Microbiol Biotechnol 2013;97:8849-57.
141. Zheng X, Ou Y, Shu M, Wang Y, Zhou Y, Su X, Zhu W, Yin W, Li S, Qiu P, Yan G, Zhang J, Hu J, Xu D. Cholera toxin, a typical protein
kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf/MEK/
ERK signaling pathway. Mol Med Rep 2014;9:1773-9.
142. Zhao Q, Qu X, Liu K, Shi H, Yang G, Zhou B, Zhu L, Zhang W, Yan Z, Liu R, Qian S, Wang J. Microwave ablation combined with
attenuated Salmonella typhimurium for treating hepatocellular carcinoma in a rat model. Oncotarget 2017;8:47655-64.
143. Morgan RA, Chinnasamy N, Abate-Daga D, Gros A, Robbins PF, Zheng Z, Dudley ME, Feldman SA, Yang JC, Sherry RM, Phan GQ,
Hughes MS, Kammula US, Miller AD, Hessman CJ, Stewart AA, Restifo NP, Quezado MM, Alimchandani M, Rosenberg AZ, Nath
A, Wang T, Bielekova B, Wuest SC, Akula N, McMahon FJ, Wilde S, Mosetter B, Schendel DJ, Laurencot CM, Rosenberg SA. Cancer
regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J Immunother 2013;36:133-51.
144. Jiang SN, Phan TX, Nam TK, Nguyen VH, Kim HS, Bom HS, Choy HE, Hong Y, Min JJ. Inhibition of tumor growth and metastasis by
a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol Ther 2010;18:635-42.
145. Keates AC, Fruehauf J, Xiang S, Li CJ. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and
delivery. Biotechnol Genet Eng Rev 2008;25:113-28.
146. Yang N, Li SH, Lü YZ, Chen LS, Ren DM. Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA
interference in murine bladder tumors. Acta Pharmacol Sin 2011;32:368-74.
147. Tian Y, Guo B, Jia H, Ji K, Sun Y, Li Y, Zhao T, Gao L, Meng Y, Kalvakolanu DV, Kopecko DJ, Zhao X, Zhang L, Xu D. Targeted
therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted
mouse HCC. Cancer Gene Ther 2012;19:393-401.
148. Yu YA, Weibel S, Szalay AA. Real-time imaging of tumors using replication-competent light-emitting microorganisms. Methods Mol
Biol 2012;872:159-75.
149. Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, Burnazi EM, Ghani ER, Hricak H, Szalay AA, Fong Y, Blasberg R. Escherichia coli
Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin Cancer Res 2008;14:2295-302.
150. Viczián A, Kircher S. Luciferase and green fluorescent protein reporter genes as tools to determine protein abundance and intracellular
dynamics. Methods Mol Biol 2010;655:293-312.
151. Voisey CR, Marincs F. Elimination of internal restriction enzyme sites from a bacterial luminescence (luxCDABE) operon.
Biotechniques 1998;24:56-8.
152. Sörensen M, Lippuner C, Kaiser T, Misslitz A, Aebischer T, Bumann D. Rapidly maturing red fluorescent protein variants with strongly
enhanced brightness in bacteria. FEBS Lett 2003;552:110-4.
153. Yu YA, Zhang Q, Szalay AA. Establishment and characterization of conditions required for tumor colonization by intravenously
delivered bacteria. Biotechnol Bioeng 2008;100:567-78.
154. Araujo AC, Abreu F, Silva KT, Bazylinski DA, Lins U. Magnetotactic bacteria as potential sources of bioproducts. Mar Drugs
2015;13:389-430.
155. Nakamura C, Burgess JG, Sode K, Matsunaga T. An iron-regulated gene, magA, encoding an iron transport protein of magnetospirillum
sp. strain AMB-1. J Biol Chem 1995;270:28392-6.
156. Mannucci S, Ghin L, Conti G, Tambalo S, Lascialfari A, Orlando T, Benati D, Bernardi P, Betterle N, Bassi R, Marzola P, Sbarbati A.
Magnetic nanoparticles from magnetospirillum gryphiswaldense increase the efficacy of thermotherapy in a model of colon carcinoma.
PLoS One 2014;9:e108959.
157. Want CZ, Kazmierczak RA, Eisenstark A. Straings, mechanism and perspective; Salmonella-based cancer therapy. Int J Microbiol
2016;2016:5678702.
158. Danino T, Prindle A, Kwong G, Skalak M, Li H, Allen K, Hasty J, Bhatia SN. Programmable probiotics for detection of cancer in urine.
Sci Transl Med 2015;7:289ra84.
159. Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, Sterne JA. Protection
by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2013;58:470-80.
160. Kassouf W, Traboulsi SL, Kulkarni GS, Breau RH, Zlotta A, Fairey A, So A, Lacombe L, Rendon R, Aprikian AG, Siemens DR, Izawa
JI, Black P. CUA guidelines on the management of non-muscle invasive bladder cancer. Can Urol Assoc J 2015;9:690.